-
FDA blasts India's Vega Life Sciences over deleted data from faulty solvent testingThe laundry list of potential faults during an FDA inspection runs long, but brazen errorstend to get investigators especially riled up. That was certainly the case with Indian drugmaker Vega Life Sc2020/7/10
-
Mylan recalls lot of injectable daptomycin after particulates show up in vialOn the heels of a carcinogen scare that drove the company to pull three lots of a short-term ulcer treatment in January, Mylan has issued another recall, this time over particles found in a sample vi2020/7/9
-
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hintAs Amgen ramps up a clinical trial of its psoriasis drug Otezla in COVID-19, the company’s scientists may be seriously considering whether another of its blockbuster anti-inflammatories, Enbrel, coul2020/7/9
-
AstraZeneca, Lilly, Sanofi and others raise prices to start July: reportA pandemic hasn’t stopped some pharma companies from implementing their traditional mid-year price hikes. AstraZeneca, for instance, raised prices on 21 medicines from 1.5% to 6% this month, GoodRxr2020/7/8
-
Lupin pulls diabetes drug metformin off shelves as carcinogen worries continue to buildDiabetes med metformin has been in the FDA's crosshairs since the agency found high levels of a probable carcinogen, NDMA, that had already triggered global recalls for Zantac and a commonly used cla2020/7/8
-
With COVID-19 vaccines coming, SiO2 injects $163M into vial production plantAs COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials manufacturerhopes to ease that strai2020/7/7
-
Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectablesThe COVID-19 pandemic and its drain on key drugs used in acute care has put an enormous strain on hospitals in desperate need of medicines for their patients. In a move to shore up chronic shortages2020/7/7
-
EU in 'constructive' talks with Gilead to nab remdesivir amid U.S. supply grab: reportWhen it comes to pandemic drug supply, it’s every country for itself. That’s the message the rest of the world got from the Trump administration’s deal to lockup almost all doses of Gilead Sciences’2020/7/6
-
Bayer hits Roundup settlement snag as judge 'tentatively inclined' to reject $1.25B dealLooks like Bayer’s Roundup litigation headache may not be over after all, even after the company committed nearly $11 billion to a settlement. U.S. District Judge Vince Chhabria, who oversees the cla2020/7/6
-
Novavax inks $1.6B Warp Speed deal to fund COVID vaccine's phase 3 testing, manufacturingNovavax and its COVID-19 shot are racing against well-funded global pharmaceutical players, but a new deal with the U.S. government will push the biotech's fundraising haul past $2 billion. The Maryl2020/7/3